259 related articles for article (PubMed ID: 23613784)
1. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
[TBL] [Abstract][Full Text] [Related]
2. Imaging-based differential diagnosis between multiple system atrophy and Parkinson's disease.
Sako W; Abe T; Murakami N; Miyazaki Y; Izumi Y; Harada M; Kaji R
J Neurol Sci; 2016 Sep; 368():104-8. PubMed ID: 27538610
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
Treglia G; Stefanelli A; Cason E; Cocciolillo F; Di Giuda D; Giordano A
Clin Neurol Neurosurg; 2011 Dec; 113(10):823-9. PubMed ID: 21962800
[TBL] [Abstract][Full Text] [Related]
4.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
5. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
[TBL] [Abstract][Full Text] [Related]
6. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B
J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250
[TBL] [Abstract][Full Text] [Related]
9. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
10. Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
Sakuramoto H; Fujita H; Suzuki K; Matsubara T; Watanabe Y; Hamaguchi M; Hirata K
Clin Park Relat Disord; 2020; 2():20-24. PubMed ID: 34316615
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
Oka H; Mochio S; Yoshioka M; Morita M; Onouchi K; Inoue K
Acta Neurol Scand; 2006 Apr; 113(4):221-7. PubMed ID: 16542160
[TBL] [Abstract][Full Text] [Related]
13. Characterization and diagnostic potential of diffusion tractography in multiple system atrophy.
Beliveau V; Krismer F; Skalla E; Schocke MM; Gizewski ER; Wenning GK; Poewe W; Seppi K; Scherfler C
Parkinsonism Relat Disord; 2021 Apr; 85():30-36. PubMed ID: 33713904
[TBL] [Abstract][Full Text] [Related]
14. Correlation with sympathetic skin response,
Ozawa M; Morishima R; Shimizu T; Takahashi K
Neurophysiol Clin; 2024 Jul; 54(4):102956. PubMed ID: 38422587
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy.
Ito M; Watanabe H; Kawai Y; Atsuta N; Tanaka F; Naganawa S; Fukatsu H; Sobue G
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):722-8. PubMed ID: 17353258
[TBL] [Abstract][Full Text] [Related]
16. Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging.
Marini C; Bandettini di Poggio M; Pomposelli E; Marchese R; Nobili F; Morbelli SD; Villa G; Abbruzzese G; Sambuceti G
Clin Nucl Med; 2010 May; 35(5):311-6. PubMed ID: 20395701
[TBL] [Abstract][Full Text] [Related]
17. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A
Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242
[TBL] [Abstract][Full Text] [Related]
18. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.
Lee PH; Yeo SH; Kim HJ; Youm HY
Mov Disord; 2006 Nov; 21(11):1975-7. PubMed ID: 16960860
[TBL] [Abstract][Full Text] [Related]
19. Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.
Yamashita F; Hirayama M; Nakamura T; Takamori M; Hori N; Uchida K; Hama T; Sobue G
Clin Auton Res; 2010 Jun; 20(3):191-7. PubMed ID: 20127386
[TBL] [Abstract][Full Text] [Related]
20. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
Matsui H; Udaka F; Oda M; Tamura A; Kubori T; Nishinaka K; Kameyama M
Ann Nucl Med; 2005 May; 19(3):225-9. PubMed ID: 15981676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
